Citation: Etm. Smyth et Gs. Tillotson, SEQUENTIAL ANTIMICROBIAL THERAPY - COMPARISON OF THE VIEWS OF MICROBIOLOGISTS AND PHARMACISTS, The Journal of infection, 37, 1998, pp. 18-23
Citation: A. Anzueto et al., ETIOLOGY, SUSCEPTIBILITY, AND TREATMENT OF ACUTE BACTERIAL EXACERBATIONS OF COMPLICATED CHRONIC-BRONCHITIS IN THE PRIMARY-CARE SETTING - CIPROFLOXACIN 750 MG BID VERSUS CLARITHROMYCIN 500 MG BID, Clinical therapeutics, 20(5), 1998, pp. 885-900
Authors:
ANZUETO A
NIEDERMAN MS
HAVERSTOCK DC
TILLOTSON GS
Citation: A. Anzueto et al., EFFICACY OF CIPROFLOXACIN AND CLARITHROMYCIN IN ACUTE BACTERIAL EXACERBATIONS OF COMPLICATED CHRONIC-BRONCHITIS - INTERIM ANALYSIS, Clinical therapeutics, 19(5), 1997, pp. 989-1001
Citation: Jj. Schentag et Gs. Tillotson, ANTIBIOTIC SELECTION AND DOSING FOR THE TREATMENT OF ACUTE EXACERBATIONS OF COPD, Chest, 112(6), 1997, pp. 314-319
Citation: Gs. Tillotson, QUINOLONES - STRUCTURE-ACTIVITY-RELATIONSHIPS AND FUTURE PREDICTIONS, Journal of Medical Microbiology, 44(5), 1996, pp. 320-324
Citation: Wz. Mehal et al., ANTIBIOTIC-PROPHYLAXIS FOR ERCP - A RANDOMIZED CLINICAL-TRIAL COMPARING CIPROFLOXACIN AND CEFUROXIME IN 200 PATIENTS AT HIGH-RISK OF CHOLANGITIS, European journal of gastroenterology & hepatology, 7(9), 1995, pp. 841-845
Citation: Cj. Coe et al., INTERACTION OF SUB-INHIBITORY CONCENTRATIONS OF CIPROFLOXACIN AND RIFAMPICIN AGAINST STAPHYLOCOCCUS-AUREUS, International journal of antimicrobial agents, 5(2), 1995, pp. 135-139
Citation: Sa. Doss et al., IN-VITRO AND IN-VIVO SELECTION OF STAPHYLOCOCCUS-AUREUS MUTANTS RESISTANT TO CIPROFLOXACIN, Journal of antimicrobial chemotherapy, 35(1), 1995, pp. 95-102
Citation: Ap. Ball et Gs. Tillotson, LOWER RESPIRATORY-TRACT INFECTION THERAPY - THE ROLE OF CIPROFLOXACIN, Journal of international medical research, 23(5), 1995, pp. 315-327
Authors:
CUEVAS LE
KAZEMBE P
MUGHOGHO GK
TILLOTSON GS
HART CA
Citation: Le. Cuevas et al., ERADICATION OF NASOPHARYNGEAL CARRIAGE OF NEISSERIA-MENINGITIDIS IN CHILDREN AND ADULTS IN RURAL AFRICA - A COMPARISON OF CIPROFLOXACIN ANDRIFAMPICIN, The Journal of infectious diseases, 171(3), 1995, pp. 728-731
Authors:
COOKE J
CAIRNS CJ
TILLOTSON GS
CONNER S
LEWIN SKM
NICHOLLS J
TREDREE RL
WILLIS JV
HITCHINGS CR
Citation: J. Cooke et al., COMPARATIVE CLINICAL, MICROBIOLOGIC, AND ECONOMIC AUDIT OF THE USE OFORAL CIPROFLOXACIN AND PARENTERAL ANTIMICROBIALS, The Annals of pharmacotherapy, 27(6), 1993, pp. 785-789
Authors:
GREEN SDR
ILUNGA F
CHEESBROUGH JS
TILLOTSON GS
HICHENS M
FELMINGHAM D
Citation: Sdr. Green et al., THE TREATMENT OF NEONATAL MENINGITIS DUE TO GRAM-NEGATIVE BACILLI WITH CIPROFLOXACIN - EVIDENCE OF SATISFACTORY PENETRATION INTO THE CEREBROSPINAL-FLUID, The Journal of infection, 26(3), 1993, pp. 253-256
Citation: Sa. Doss et al., EFFECT OF SUB-INHIBITORY CONCENTRATIONS OF ANTIBIOTICS ON THE VIRULENCE OF STAPHYLOCOCCUS-AUREUS, Journal of Applied Bacteriology, 75(2), 1993, pp. 123-128
Citation: Wz. Mehal et al., ANTIBIOTIC-PROPHYLAXIS FOR ERCP - A RANDOMIZED CLINICAL-TRIAL OF CIPROFLOXACIN VERSUS CEFUROXIME, Gastroenterology, 104(4), 1993, pp. 370-370